Twist Bioscience Corporation
Twist Bioscience Corporation, a leader in the Pharmaceutical Preparation Manufacturing industry, is headquartered in the United States. Founded in 2013, the company has rapidly established itself as a pioneer in synthetic DNA production, catering to diverse sectors including biotechnology, pharmaceuticals, and agriculture.
Twist Bioscience's innovative approach to DNA synthesis allows for high-throughput, cost-effective solutions that are unique in the market. Their core products include synthetic genes, gene fragments, and other DNA-based tools, which are essential for research and development in various scientific fields.
With a strong market position, Twist Bioscience has achieved significant milestones, including partnerships with major pharmaceutical companies and advancements in gene therapy applications. Their commitment to quality and efficiency continues to drive their success in the rapidly evolving biotechnology landscape.
-10 vs industry average
Twist Bioscience Corporation’s score of 30 is lower than 44% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Twist Bioscience Corporation?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Twist Bioscience Corporation's reported carbon emissions
Twist Bioscience Corporation, a US-based pharmaceutical preparation manufacturer, reported total emissions of approximately 3.007 million kg CO2e for the year 2024. This figure comprises Scope 1 emissions of about 7,000 kg CO2e and Scope 2 emissions of approximately 3 million kg CO2e. Data for Scope 3 emissions, specifically purchased goods and services, was not available for this reporting period.
In terms of climate commitments, Twist Bioscience Corporation has a near-term target status of "Committed" as of October 23, 2025. The company's emission reporting for 2024 also includes a production emission factor of 28,400 kg CO2e per oligo panel. Twist Bioscience Corporation's data is not cascaded from a parent or related organisation, and they are the source for their own SBTi and RTZ initiatives.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Twist Bioscience Corporation’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsFrequently asked questions
Common questions about Twist Bioscience Corporation’s sustainability data and climate commitments
Data year: 2024
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project